Medinfar

Medinfar is a leading Portuguese pharmaceutical group founded in 1970, specializing in the research, development, manufacturing, and distribution of a wide range of healthcare products. The company is a market leader in Portugal in the Consumer Health and Dermatology sectors, with a strong presence in therapeutic areas such as gastroenterology, pain management, and cardiovascular health. Medinfar operates a state-of-the-art GMP manufacturing facility in Condeixa-a-Nova and has a significant international footprint, exporting to over 70 countries. In late 2025, the company expanded its Iberian presence by acquiring a stake in the Spanish pharmaceutical firm Peroxfarma. Backed by Explorer Investments, Medinfar continues to focus on innovation through its own R&D laboratory and strategic partnerships with global pharmaceutical companies.